Other Issues

Browse Other Issues Content

The objective of this guideline is to define the minimum stability data package to support the commercial distribution of OTC monograph drug products in the United States per climatic zone.

As a direct result of the PROTECT initiative, CHPA developed a voluntary guideline for industry suggesting ways to standardize volumetric measures in dosing directions and dosing devices for oral pediatric liquid drug products.

Requirements for dietary supplement labels.

While a small select group have raised concerns about certain sunscreen ingredients, banning or restricting common UV filters could negatively impact public health.

Under the Dietary Supplement Health And Education Act of 1994 (DSHEA), the U.S. Food and Drug Administration (FDA) was given several post-marketing responsibilities to ensure the safety of dietary supplements.

CHPA is uniquely positioned to provide access to OTC medicines and dietary supplements in nearly every category that can be donated and customized to the needs of underserved communities. Our product donation initiative is an ongoing effort to support these communities. So far, CHPA member companies have donated 70,000 products to people in need.

Rather than legislate additional state-level extended producer responsibility mandates aimed at packaging, lawmakers should support manufacturers already innovating sustainability solutions within the FDA's extensive regulatory framework that balances both environmental considerations and patient safety needs.

This page serves as a central resource for the latest updates on tariffs and trade policy announcements from the White House that may impact our industry. Below is timely information including official statements and guidance for members, media, and other stakeholders navigating changes in trade and supply chain policy. We are committed to keeping you informed and engaged as we advocate for access, affordability, and innovation.

Filter Results